The above chart presents the market trend analysis for hec pharm co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 5 transactions, with a transaction quantity of 6280 and a transaction weight of 0.
YearTransactionsQuantityWeight
2025713593.360
2026562800
Bill of lading data
<
1/15
>
Trade date
2026/06/29
B/L No.
108382887540
Suppliers
hec pharm co.ltd.
Buyers
công ty cp xuất nhập khẩu y tế domesco
Product description
Nguyên liệu sản xuất thuốc ( dược chất): AZITHROMYCIN DIHYDRATE. Tiêu chuẩn : EP 11. Số lô: AZM4-202512002, nsx: 11.12.2025, hsd: 10.12.2029, dạng bột, 25kg/drum. Mới 100%
Expand
Trade date
2026/05/27
B/L No.
108282237710
Suppliers
hec pharm co.ltd.
Buyers
công ty cp xuất nhập khẩu y tế domesco
Product description
Nguyên liệu sản xuất thuốc ( dược chất): AZITHROMYCIN DIHYDRATE. Tiêu chuẩn: EP 11. Số lô: AMZ4-202512002, nsx: 11.12.2025, hsd: 10.12.2029, dạng bột, 25kg/drum. Mới 100%
Expand
Trade date
2026/02/11
B/L No.
107981424940
Suppliers
hec pharm co.ltd.
Buyers
công ty cổ phần hóa chất global hub
Product description
Nguyên liệu thuốc kháng sinh chữa bệnh cho người Azithromycin Dihydrat để sản xuất thuốc Macromax SK visa số VD-31846-19 (893110816824), TCCL: EP11.5, số lô AZM4-202410001, hàng mới 100%
Expand
Trade date
2025/03/06
B/L No.
106995843950
Suppliers
hec pharm co.ltd.
Buyers
công ty cổ phần thương mại việt uy
Product description
PHARMACEUTICAL SUBSTANCE USED FOR RESEARCH AND TESTING: CLARITHROMYCIN EP11.3; LOT: CAM-202404005; PRODUCTION: APRIL 4, 2024; HD: APRIL 3, 2028; SECTION 224; DM7; T06/18
Expand
Trade date
2024/03/12
B/L No.
——
Suppliers
hec pharm co.ltd.
Buyers
vhl international trade co., ltd
Product description
RAW MATERIALS FOR MAKING VETERINARY MEDICINE: ERYTHROMYCIN THIOCYANATE, LOT NUMBER: ETH4-202402509 (NSX: FEBRUARY 13, 2024-HSD: FEBRUARY 12, 2028), PACKED 20KG/CARTON, 100% NEW PRODUCT
Expand
Product description
RAW MATERIALS USED TO PRODUCE DRUGS: LINCOMYCIN HYDROCHLORIDE EP11.3, LOT: LCM2-202401501, LCM2-202401502, LCM2-202401503;SX:12/2023;01/2024; HD: DECEMBER 2027; MANUFACTURER: HEC PHARM CO., LTD. - CHINA (1BOU=1 UNIT)
Expand
5abbvie ltd.
united statesbuyer,they trade on 2014-10-10
33.13%
>
+View All
Products
Total 10
ProductsTransactionsPerDetail
ceftriaxone sodium 650%>
entercavir 650%>
neomycin sulphate 650%>
erythromycin 433.33%>
erythromycin ethyl succinate 433.33%>
+View All
Hscode rank
Total 6
HSCode NameTransactionsPerDetail
HS 29419000650%>
HS 29415000433.33%>
HS 29419021216.67%>
Trading Area
Total 8
AreaTransactionsPerDetail
united states4647.92%>
vietnam2526.04%>
brazil1818.75%>
indonesia22.08%>
pakistan22.08%>
+View All
Port statistics
Total 8
Port NameTransactionsPerDetail
manzanillo2728.13%>
shanghai2020.83%>
balboa66.25%>
colon66.25%>
kingston66.25%>
+View All
hec pharm co.ltd. is panama Supplier,
and primarily engages in the import and export business of products such as ceftriaxone sodium,entercavir,neomycin sulphate.
According to the 52wmb.com global trade database, as of 2026-06-29, the company has completed 96 international trades,
with its main trading regions covering united states,vietnam,brazil etc.
The core products include HS29419000,HS29415000,HS29419021 etc,
often transported via manzanillo,port shanghai, port balboa etc,
and its main trading partners are abbott phamaceutical pr ltd.,farmabase saude animal ltd.,anpharma pharmaceutical co.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on hec pharm co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.